Clinical Trial Update: Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide Taken as 5 Days Per Week [NA]

View source ↗

Summary

Clinical trial update evaluating a fixed-dose combination of bictegravir/emtricitabine/tenofovir alafenamide taken five days per week in virally suppressed peop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Virally Suppressed People With HIV | NA | Status: ACTIVE_NOT_RECRUITING